Release Date: 03/07/18 14:11 Summary: Realm Resources Limited Panel Accepts Undertakings Price Sensitive: No Download Document 157.35KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%